Description
FOX-04 DRI research peptide
FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells. It was described in a 2017 study as a selective senolytic in mouse models.
Product details
| Compound | FOXO4-DRI |
|---|---|
| Class | D-retro-inverso peptide (senolytic research) |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every container |
What FOX-04 DRI research has examined
- Senescence biology: the FOXO4–p53 interaction in senescent cells.
- Senolytic research: selective apoptosis of senescent cells in culture and mice.
- Peptide design: protease resistance of D-retro-inverso peptides.
Research interest does not establish a proven effect in humans.
Regulatory status
FOX-04 DRI is not an approved medicine. It is supplied only as a research chemical for laboratory use.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Adamax / Adalank Combo Pack · Healing Research Bundle · Turn Back Time Bundle · All peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.